How does the genetic test change the cost conversation
Many patients with rheumatoid arthritis and psoriatic arthritis and other conditions live with overweight and obesity
Combining these advancements with other treatment modalities may further optimize their potential, creating a more comprehensive framework for managing T2DM and related metabolic disorders
Consensus reports are a key step in driving clinical adoption of these therapies if they become FDA-approved for T1D in the future, and Breakthrough T1D endorses this report alongside five international diabetes organizations
The decision to switch should involve shared decision-making between patient and clinician, considering HbA1c targets, weight management goals, cardiovascular risk profile, and individual preferences
Rather than stopping abruptly, some prescribers recommend gradually extending the interval between doses